Understanding Polymorphic Control of Pharmaceuticals Using lmidazolium-Based Ionic Liquid Mixtures as Crystallization Directing Agents

resumo

Imidazolium-based room temperature ionic liquids (RTILs) were tested to assess their ability to control molecular polymorphic behavior. Mixtures of RTILs with distinct cation/anion combinations revealed promising capabilities in directing the crystallization process toward less stable polymorphs. In our tests, gabapentin (GBP) neuroleptic drug was used as a case study, as it is a well know polymorphic active pharmaceutical ingredient. For the first time, pure "bulk" GBP Form IV, a highly unstable polymorph, was isolated through RTILs. Forms were maintained over time, once they were kept soaked, opening new perspectives for the method presented here. Molecular dynamics (MD) simulations clearly supported the results. In this work the polymorphic behavior of GBP is controlled recurring to the use of different pure imidazolium-based RTILs or mixtures, as crystallization solvents. Molecular dynamics simulations clearly supported the results showing that specific H((addic)((C4/C6mim)))center dot center dot center dot O-carboxylate interaction between GBP and RTILs drives the formation of Form IV. For the first time, pure "bulk" GBP Form IV, a highly unstable polymorph, was isolated. These results showed the importance of these "directing agents" in the polymorphic process as well as the importance of using MD simulations in predicting the "designed" crystallization environment for the "desired" polymorph.

palavras-chave

SOLID-STATE; GABAPENTIN; DESIGN; FORMS; INGREDIENTS; SEPARATION; SOLVENTS

categoria

Chemistry; Crystallography; Materials Science

autores

Martins, ICB; Gomes, JRB; Duarte, MT; Mafra, L

nossos autores

agradecimentos

Investigator FCT and SFRH/BD/93140/2013 by Fundacao para a Ciencia e a Tecnologia and FEDER (PT2020 Partnership Agreement).

Partilhe este projeto

Publicações similares

Usamos cookies para atividades de marketing e para lhe oferecer uma melhor experiência de navegação. Ao clicar em “Aceitar Cookies” você concorda com nossa política de cookies. Leia sobre como usamos cookies clicando em "Política de Privacidade e Cookies".